4.7 Article

Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters

期刊

GASTROINTESTINAL ENDOSCOPY
卷 73, 期 6, 页码 1174-1180

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.gie.2011.01.018

关键词

-

资金

  1. Canadian Institutes of Health Research/Canadian Association of Gastroenterology
  2. Canada Foundation for Innovation

向作者/读者索取更多资源

Background: Epithelial gaps created by shedding of epithelial cells in the small intestine can be visualized by using confocal laser endomicroscopy (CLE). The density of epithelial gaps in the small bowels of patients with inflammatory bowel disease (IBD) and controls without IBD is unknown. Objective: To determine whether the epithelial gap density in patients with IBD is different from that in controls. Design: Prospective, controlled, cohort study. Setting: A tertiary-care referral center. Patients: This study involved patients with IBD and control patients without IBD undergoing colonoscopy. Intervention: Probe-based CLE (pCLE) was used to image the terminal ileum. Main Outcome Measurements: The primary outcome of the study was gap density, defined as the total number of gaps per 1000 cells counted in adequately imaged villi by using pCLE. The pCLE images were blindly reviewed, and the number of epithelial gaps and cells were manually counted. The secondary outcomes were correlation of gap density with disease activity, location, and severity of clinical disease. Results: There were 30 controls and 28 patients with IBD. Of the patients with IBD, 16 had Crohn's disease, and 12 had ulcerative colitis. The median epithelial gap densities for controls and patients with IBD were 18 and 61 gaps/1000 cells, respectively (P < .001). Gap density did not correlate with disease activity. Patients with ulcerative pan-colitis tended toward gap densities lower than those of patients with limited colitis (32 versus 97 gaps/1000 cells, P = .06). Patients with IBD with severe clinical disease also had lower median gap densities (37 vs 90 gaps/1000 cells, P = .04). Limitations: A single-center study. Conclusion: The epithelial gap density was significantly increased in patients with IBD compared with controls. (Clinical trial registration number: NCT00988273.) (Gastrointest Endosc 2011;73:1174-80.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

A Distinctive Urinary Metabolomic Fingerprint Is Linked With Endoscopic Postoperative Disease Recurrence in Crohn's Disease Patients

Ammar Hassanzadeh Keshteli, Robert Tso, Levinus A. Dieleman, Heekuk Park, Karen I. Kroeker, Juan Jovel, Patrick M. Gillevet, Masoumeh Sikaroodi, Rupasri Mandal, Richard N. Fedorak, Karen L. Madsen

INFLAMMATORY BOWEL DISEASES (2018)

Article Gastroenterology & Hepatology

Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy

Garett Dunsmore, Petya Koleva, Nafiseh Ghobakhloo, Reed Sutton, Lindsy Ambrosio, Xuanyi Meng, Naomi Hotte, Vivian Nguyen, Karen L. Madsen, Levinus A. Dieleman, Vivian Huang, Shokrollah Elahi

JOURNAL OF CROHNS & COLITIS (2019)

Article Gastroenterology & Hepatology

The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn

Xuanyi Meng, Garett Dunsmore, Petya Koleva, Yesmine Elloumi, Richard You Wu, Reed Taylor Sutton, Lindsy Ambrosio, Naomi Hotte, Vivian Nguyen, Karen L. Madsen, Levinus A. Dieleman, Hongbing Chen, Vivian Huang, Shokrollah Elahi

JOURNAL OF CROHNS & COLITIS (2019)

Article Microbiology

Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases

Heather Armstrong, Misagh Alipour, Rosica Valcheva, Michael Bording-Jorgensen, Juan Jovel, Deenaz Zaidi, Prachi Shah, Yuefei Lou, Cory Ebeling, Andrew L. Mason, Dawson Lafleur, Jeremy Jerasi, Gane K. -S. Wong, Karen Madsen, Matthew W. Carroll, Hien Q. Huynh, Levinus A. Dieleman, Eytan Wine

MICROBIOME (2019)

Article Gastroenterology & Hepatology

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers

Ammar Hassanzadeh Keshteli, Karen L. Madsen, Rupasri Mandal, Guy E. Boeckxstaens, Premysl Bercik, Giada De Palma, David E. Reed, David Wishart, Stephen Vanner, Levinus A. Dieleman

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Editorial Material Gastroenterology & Hepatology

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply

Ammar Hassanzadeh Keshteli, Karen L. Madsen, Rupasri Mandal, Guy E. Boeckxstaens, Premysl Bercik, Giada De Palma, David E. Reed, David Wishart, Stephen Vanner, Levinus A. Dieleman

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Medicine, General & Internal

Surveys of parents and clinicians concerning the minimally important difference of probiotic therapy for prevention of paediatric antibiotic-associated diarrhoea

Samaneh Khanpour Ardestani, Joan L. Robinson, Levinus A. Dieleman, Hien Q. Huynh, Hsing Jou, Sunita Vohra

BMJ OPEN (2019)

Review Nutrition & Dietetics

Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions

Ammar Hassanzadeh Keshteli, Karen L. Madsen, Levinus A. Dieleman

NUTRIENTS (2019)

Review Nutrition & Dietetics

The Gut Microbiota in Celiac Disease and Probiotics

Richa Chibbar, Levinus A. Dieleman

NUTRIENTS (2019)

Article Gastroenterology & Hepatology

Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease

Parul Tandon, Eugenia Y. Lee, Cynthia Maxwell, Lara Hitz, Lindsy Ambrosio, Levinus Dieleman, Brendan Halloran, Karen Kroeker, Vivian M. Huang

Summary: Elevated fecal calprotectin levels during pregnancy in patients with inflammatory bowel disease may be associated with adverse pregnancy outcomes, serving as a potential marker for prediction.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Genetics & Heredity

Associations ofNOD2polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects

Williams Turpin, Larbi Bedrani, Osvaldo Espin-Garcia, Wei Xu, Mark S. Silverberg, Michelle I. Smith, Juan Antonio Raygoza Garay, Sun-Ho Lee, David S. Guttman, Anne Griffiths, Paul Moayyedi, Remo Panaccione, Hien Huynh, Hillary A. Steinhart, Guy Aumais, Levinus A. Dieleman, Dan Turner, Andrew D. Paterson, Kenneth Croitoru

BMC MEDICAL GENETICS (2020)

Article Medicine, General & Internal

IMAGINE Network's Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome

Paul Moayyedi, Glenda MacQueen, Charles N. Bernstein, Stephen Vanner, Premysl Bercik, Karen L. Madsen, Michael Surette, John D. Rioux, Levinus A. Dieleman, Elena Verdu, Russell J. de Souza, Anthony Otley, Laura Targownik, John Lavis, Jennifer Cunningham, Deborah A. Marshall, Sandra Zelinsky, Aida Fernandes

BMJ OPEN (2020)

Review Medicine, General & Internal

Refractory Celiac Disease Type II: A Case Report and Literature Review

Richa Chibbar, Jordan Nostedt, Dana Mihalicz, Jean Deschenes, Ross McLean, Levinus A. Dieleman

FRONTIERS IN MEDICINE (2020)

Article Gastroenterology & Hepatology

Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial

Bhairavi Balram, Harshad Joshi, Karen Wong, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Daniel C. Baumgart, Farhad Peerani

Summary: This study found that continuing 5-ASA therapy in ulcerative colitis patients escalated to infliximab did not provide additional benefit in controlling inflammation, and was not associated with increased likelihood of achieving clinical and endoscopic remission.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Gastroenterology & Hepatology

Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels

Rosica Valcheva, Petya Koleva, Ines Martinez, Jens Walter, Michael G. Ganzle, Levinus A. Dieleman

GUT MICROBES (2019)

暂无数据